Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-01

AUTHORS

Shohei Koyama, Naoto Koike, Shinya Adachi

ABSTRACT

We investigated the presence and functional status of surface expression of the Fas receptor (FasR) and its ligand (FasL) in tumor and tumor-infiltrating lymphocytes (TIL) in gastric carcinoma (n=36) from the primary locus, metastatic gastric carcinoma (n=30) from malignant ascites, and benign gastric mucosa (n=30) for the control. The quantitative analysis was based on the percentage of positive cells by a flow cytometry. The results showed that the membrane-bound FasL molecule was constitutively expressed in primary and metastatic gastric carcinomas as well as normal gastric epithelium in nearly all the patients. In particular, metastatic carcinoma proved to aberrantly express the FasL molecule. On the other hand, FasR expression ranged from minimal or absent in primary and metastatic gastric carcinomas, suggesting that the carcinoma might be rendered less sensitive toward FasR-induced killing. Apoptotic tumor cells detected by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick and labeling (TUNEL) were barely identified in primary and metastatic carcinomas. In the analysis of TIL, the expression of FasR and FasL, and apoptotic TIL could not usually be observed in primary gastric carcinoma. In metastatic carcinoma, however, there was significant overexpression of FasR and FasL in immune TIL associated with a higher frequency of apoptotic cell death detected by TUNEL. The results suggest that metastatic carcinoma expressing FasL, but not FasL+ primary carcinoma, might evade the immune attack by apoptotic depletion of activated TIL through the FasR/FasL systems. These results provide the direct and quantitative evidence of FasR counterattacks and/or paracrine fratricides as a mechanism of tumor-immune escape in vivo in human cancer. More... »

PAGES

20-26

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s004320000181

DOI

http://dx.doi.org/10.1007/s004320000181

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1052848144

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11206267


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ascites", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Membrane", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Separation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Epithelium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fas Ligand Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Flow Cytometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Situ Nick-End Labeling", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocytes, Tumor-Infiltrating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Membrane Glycoproteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stomach Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "fas Receptor", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, 305-8575 Japan e-mail: s-koyama@md.tsukuba.ac.jp Tel.: +81-298-533210; Fax: +81-298-533039, JP", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, 305-8575 Japan e-mail: s-koyama@md.tsukuba.ac.jp Tel.: +81-298-533210; Fax: +81-298-533039, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koyama", 
        "givenName": "Shohei", 
        "id": "sg:person.0657656236.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657656236.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Koike", 
        "givenName": "Naoto", 
        "id": "sg:person.01330372147.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330372147.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, Japan, JP", 
          "id": "http://www.grid.ac/institutes/grid.20515.33", 
          "name": [
            "Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, Japan, JP"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Adachi", 
        "givenName": "Shinya", 
        "id": "sg:person.0743060207.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743060207.94"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2001-01", 
    "datePublishedReg": "2001-01-01", 
    "description": "Abstract We investigated the presence and functional status of surface expression of the Fas receptor (FasR) and its ligand (FasL) in tumor and tumor-infiltrating lymphocytes (TIL) in gastric carcinoma (n=36) from the primary locus, metastatic gastric carcinoma (n=30) from malignant ascites, and benign gastric mucosa (n=30) for the control. The quantitative analysis was based on the percentage of positive cells by a flow cytometry. The results showed that the membrane-bound FasL molecule was constitutively expressed in primary and metastatic gastric carcinomas as well as normal gastric epithelium in nearly all the patients. In particular, metastatic carcinoma proved to aberrantly express the FasL molecule. On the other hand, FasR expression ranged from minimal or absent in primary and metastatic gastric carcinomas, suggesting that the carcinoma might be rendered less sensitive toward FasR-induced killing. Apoptotic tumor cells detected by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick and labeling (TUNEL) were barely identified in primary and metastatic carcinomas. In the analysis of TIL, the expression of FasR and FasL, and apoptotic TIL could not usually be observed in primary gastric carcinoma. In metastatic carcinoma, however, there was significant overexpression of FasR and FasL in immune TIL associated with a higher frequency of apoptotic cell death detected by TUNEL. The results suggest that metastatic carcinoma expressing FasL, but not FasL+ primary carcinoma, might evade the immune attack by apoptotic depletion of activated TIL through the FasR/FasL systems. These results provide the direct and quantitative evidence of FasR counterattacks and/or paracrine fratricides as a mechanism of tumor-immune escape in vivo in human cancer.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s004320000181", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "127"
      }
    ], 
    "keywords": [
      "tumor-infiltrating lymphocytes", 
      "metastatic gastric carcinoma", 
      "metastatic carcinoma", 
      "gastric carcinoma", 
      "analysis of TIL", 
      "apoptotic tumor-infiltrating lymphocytes", 
      "FasL molecules", 
      "tumor immune escape", 
      "expression of FasR", 
      "benign gastric mucosa", 
      "normal gastric epithelium", 
      "apoptotic tumor cells", 
      "primary gastric carcinomas", 
      "malignant ascites", 
      "primary carcinoma", 
      "functional status", 
      "immune attack", 
      "immune escape", 
      "apoptotic depletion", 
      "gastric mucosa", 
      "positive cells", 
      "carcinoma", 
      "gastric epithelium", 
      "terminal deoxynucleotidyl transferase", 
      "flow cytometry", 
      "FasR expression", 
      "significant overexpression", 
      "tumor cells", 
      "FasL system", 
      "dUTP nick", 
      "apoptotic cell death", 
      "human cancers", 
      "surface expression", 
      "FasL", 
      "Fas receptor", 
      "deoxynucleotidyl transferase", 
      "lymphocytes", 
      "cell death", 
      "FasR", 
      "vivo", 
      "expression", 
      "primary locus", 
      "ascites", 
      "cells", 
      "patients", 
      "mucosa", 
      "high frequency", 
      "tumors", 
      "cancer", 
      "epithelium", 
      "receptors", 
      "cytometry", 
      "TUNEL", 
      "death", 
      "overexpression", 
      "killing", 
      "status", 
      "escape", 
      "transferase", 
      "mechanism", 
      "percentage", 
      "quantitative evidence", 
      "evidence", 
      "depletion", 
      "control", 
      "labeling", 
      "quantitative analysis", 
      "fratricide", 
      "results", 
      "nick", 
      "analysis", 
      "presence", 
      "molecules", 
      "frequency", 
      "counterattack", 
      "hand", 
      "ligands", 
      "loci", 
      "attacks", 
      "Abstract", 
      "system"
    ], 
    "name": "Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma", 
    "pagination": "20-26", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1052848144"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s004320000181"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11206267"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s004320000181", 
      "https://app.dimensions.ai/details/publication/pub.1052848144"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_343.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s004320000181"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s004320000181'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s004320000181'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s004320000181'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s004320000181'


 

This table displays all metadata directly associated to this object as RDF triples.

234 TRIPLES      20 PREDICATES      126 URIs      118 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s004320000181 schema:about N0717cbab0579424dbfe2cee6f93d2346
2 N1b571af5213247678b9e9c04ef7531f7
3 N29de6939865f44399e2314ba842e0c64
4 N37bf166f1b79400fbfda6db86bd909ee
5 N38be491c10c2438a9847b054718ef24d
6 N686771f56b814df7a170e73fb562bb5e
7 N6bce0ad8ba8d48fd984763ea86bb12c6
8 N7f99931deb0f411f9378c2fa16d330b7
9 N80f75f2d07d54a72be328576fdd9e323
10 N8796fd51748d4ac58b93f39008618f07
11 N9ced08f22cdd4bb5a6b1b0900b4fb0aa
12 Na8fa4626fffd412dba699e95057096c3
13 Na94b6fd32a4544de884b38ba764ee1bb
14 Nb410e47e9619403d89b8a919c0d575da
15 Nd2f866d912ee442ba3301337f87e3bee
16 Nd9566a72cd5847149948cca5a1ccd164
17 Ndb8410d541b04f31aa4873432bc99d8a
18 Ne8e239880eeb470297e1fdfd78747d9c
19 Ned08398cddc747fcb7884fde56e3b423
20 anzsrc-for:11
21 anzsrc-for:1107
22 schema:author Na107856a615e4093904f20a2fa5ace0a
23 schema:datePublished 2001-01
24 schema:datePublishedReg 2001-01-01
25 schema:description Abstract We investigated the presence and functional status of surface expression of the Fas receptor (FasR) and its ligand (FasL) in tumor and tumor-infiltrating lymphocytes (TIL) in gastric carcinoma (n=36) from the primary locus, metastatic gastric carcinoma (n=30) from malignant ascites, and benign gastric mucosa (n=30) for the control. The quantitative analysis was based on the percentage of positive cells by a flow cytometry. The results showed that the membrane-bound FasL molecule was constitutively expressed in primary and metastatic gastric carcinomas as well as normal gastric epithelium in nearly all the patients. In particular, metastatic carcinoma proved to aberrantly express the FasL molecule. On the other hand, FasR expression ranged from minimal or absent in primary and metastatic gastric carcinomas, suggesting that the carcinoma might be rendered less sensitive toward FasR-induced killing. Apoptotic tumor cells detected by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick and labeling (TUNEL) were barely identified in primary and metastatic carcinomas. In the analysis of TIL, the expression of FasR and FasL, and apoptotic TIL could not usually be observed in primary gastric carcinoma. In metastatic carcinoma, however, there was significant overexpression of FasR and FasL in immune TIL associated with a higher frequency of apoptotic cell death detected by TUNEL. The results suggest that metastatic carcinoma expressing FasL, but not FasL+ primary carcinoma, might evade the immune attack by apoptotic depletion of activated TIL through the FasR/FasL systems. These results provide the direct and quantitative evidence of FasR counterattacks and/or paracrine fratricides as a mechanism of tumor-immune escape in vivo in human cancer.
26 schema:genre article
27 schema:isAccessibleForFree false
28 schema:isPartOf N50edaea8c32b4f18b6a25b3e2be81fcc
29 N77cd991482644f4eb36e37ba694931af
30 sg:journal.1313647
31 schema:keywords Abstract
32 Fas receptor
33 FasL
34 FasL molecules
35 FasL system
36 FasR
37 FasR expression
38 TUNEL
39 analysis
40 analysis of TIL
41 apoptotic cell death
42 apoptotic depletion
43 apoptotic tumor cells
44 apoptotic tumor-infiltrating lymphocytes
45 ascites
46 attacks
47 benign gastric mucosa
48 cancer
49 carcinoma
50 cell death
51 cells
52 control
53 counterattack
54 cytometry
55 dUTP nick
56 death
57 deoxynucleotidyl transferase
58 depletion
59 epithelium
60 escape
61 evidence
62 expression
63 expression of FasR
64 flow cytometry
65 fratricide
66 frequency
67 functional status
68 gastric carcinoma
69 gastric epithelium
70 gastric mucosa
71 hand
72 high frequency
73 human cancers
74 immune attack
75 immune escape
76 killing
77 labeling
78 ligands
79 loci
80 lymphocytes
81 malignant ascites
82 mechanism
83 metastatic carcinoma
84 metastatic gastric carcinoma
85 molecules
86 mucosa
87 nick
88 normal gastric epithelium
89 overexpression
90 patients
91 percentage
92 positive cells
93 presence
94 primary carcinoma
95 primary gastric carcinomas
96 primary locus
97 quantitative analysis
98 quantitative evidence
99 receptors
100 results
101 significant overexpression
102 status
103 surface expression
104 system
105 terminal deoxynucleotidyl transferase
106 transferase
107 tumor cells
108 tumor immune escape
109 tumor-infiltrating lymphocytes
110 tumors
111 vivo
112 schema:name Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma
113 schema:pagination 20-26
114 schema:productId N1ae19160dc8246c483d8a6c591e65446
115 Na4d727700c804b80a2e22a31e269072b
116 Nbda2a2ef44ef4239a86efa525b25a6e3
117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052848144
118 https://doi.org/10.1007/s004320000181
119 schema:sdDatePublished 2022-10-01T06:31
120 schema:sdLicense https://scigraph.springernature.com/explorer/license/
121 schema:sdPublisher N308fa9d3205748aeac488e8abfb0ca3e
122 schema:url https://doi.org/10.1007/s004320000181
123 sgo:license sg:explorer/license/
124 sgo:sdDataset articles
125 rdf:type schema:ScholarlyArticle
126 N0717cbab0579424dbfe2cee6f93d2346 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Lymphocytes, Tumor-Infiltrating
128 rdf:type schema:DefinedTerm
129 N1ae19160dc8246c483d8a6c591e65446 schema:name pubmed_id
130 schema:value 11206267
131 rdf:type schema:PropertyValue
132 N1b571af5213247678b9e9c04ef7531f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Cell Membrane
134 rdf:type schema:DefinedTerm
135 N29de6939865f44399e2314ba842e0c64 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Aged
137 rdf:type schema:DefinedTerm
138 N308fa9d3205748aeac488e8abfb0ca3e schema:name Springer Nature - SN SciGraph project
139 rdf:type schema:Organization
140 N37bf166f1b79400fbfda6db86bd909ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Humans
142 rdf:type schema:DefinedTerm
143 N38be491c10c2438a9847b054718ef24d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Epithelium
145 rdf:type schema:DefinedTerm
146 N4ff5acfe89d6461080c7047c2101205f rdf:first sg:person.0743060207.94
147 rdf:rest rdf:nil
148 N50edaea8c32b4f18b6a25b3e2be81fcc schema:issueNumber 1
149 rdf:type schema:PublicationIssue
150 N686771f56b814df7a170e73fb562bb5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Middle Aged
152 rdf:type schema:DefinedTerm
153 N6bce0ad8ba8d48fd984763ea86bb12c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Aged, 80 and over
155 rdf:type schema:DefinedTerm
156 N77cd991482644f4eb36e37ba694931af schema:volumeNumber 127
157 rdf:type schema:PublicationVolume
158 N7f99931deb0f411f9378c2fa16d330b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Flow Cytometry
160 rdf:type schema:DefinedTerm
161 N80f75f2d07d54a72be328576fdd9e323 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name fas Receptor
163 rdf:type schema:DefinedTerm
164 N8796fd51748d4ac58b93f39008618f07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Ascites
166 rdf:type schema:DefinedTerm
167 N9ced08f22cdd4bb5a6b1b0900b4fb0aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Apoptosis
169 rdf:type schema:DefinedTerm
170 Na107856a615e4093904f20a2fa5ace0a rdf:first sg:person.0657656236.00
171 rdf:rest Nc623698cc0d04639a83338c441bd69f0
172 Na4d727700c804b80a2e22a31e269072b schema:name doi
173 schema:value 10.1007/s004320000181
174 rdf:type schema:PropertyValue
175 Na8fa4626fffd412dba699e95057096c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Carcinoma
177 rdf:type schema:DefinedTerm
178 Na94b6fd32a4544de884b38ba764ee1bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Antibodies, Monoclonal
180 rdf:type schema:DefinedTerm
181 Nb410e47e9619403d89b8a919c0d575da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name In Situ Nick-End Labeling
183 rdf:type schema:DefinedTerm
184 Nbda2a2ef44ef4239a86efa525b25a6e3 schema:name dimensions_id
185 schema:value pub.1052848144
186 rdf:type schema:PropertyValue
187 Nc623698cc0d04639a83338c441bd69f0 rdf:first sg:person.01330372147.74
188 rdf:rest N4ff5acfe89d6461080c7047c2101205f
189 Nd2f866d912ee442ba3301337f87e3bee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Cell Separation
191 rdf:type schema:DefinedTerm
192 Nd9566a72cd5847149948cca5a1ccd164 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Stomach Neoplasms
194 rdf:type schema:DefinedTerm
195 Ndb8410d541b04f31aa4873432bc99d8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Membrane Glycoproteins
197 rdf:type schema:DefinedTerm
198 Ne8e239880eeb470297e1fdfd78747d9c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Adult
200 rdf:type schema:DefinedTerm
201 Ned08398cddc747fcb7884fde56e3b423 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
202 schema:name Fas Ligand Protein
203 rdf:type schema:DefinedTerm
204 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
205 schema:name Medical and Health Sciences
206 rdf:type schema:DefinedTerm
207 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
208 schema:name Immunology
209 rdf:type schema:DefinedTerm
210 sg:journal.1313647 schema:issn 0171-5216
211 1432-1335
212 schema:name Journal of Cancer Research and Clinical Oncology
213 schema:publisher Springer Nature
214 rdf:type schema:Periodical
215 sg:person.01330372147.74 schema:affiliation grid-institutes:grid.20515.33
216 schema:familyName Koike
217 schema:givenName Naoto
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330372147.74
219 rdf:type schema:Person
220 sg:person.0657656236.00 schema:affiliation grid-institutes:grid.20515.33
221 schema:familyName Koyama
222 schema:givenName Shohei
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657656236.00
224 rdf:type schema:Person
225 sg:person.0743060207.94 schema:affiliation grid-institutes:grid.20515.33
226 schema:familyName Adachi
227 schema:givenName Shinya
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743060207.94
229 rdf:type schema:Person
230 grid-institutes:grid.20515.33 schema:alternateName Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, 305-8575 Japan e-mail: s-koyama@md.tsukuba.ac.jp Tel.: +81-298-533210; Fax: +81-298-533039, JP
231 Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, Japan, JP
232 schema:name Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, 305-8575 Japan e-mail: s-koyama@md.tsukuba.ac.jp Tel.: +81-298-533210; Fax: +81-298-533039, JP
233 Department of Surgery, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-City, Ibaraki, Japan, JP
234 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...